LKT Labs

Biochemicals for Life Science Research

(E,Z)-4-Hydroxytamoxifen

(E,Z)-4-Hydroxytamoxifen

Product ID H9716
Cas No. 68392-35-8
Purity ≥97%
Product Unit SizeCostQuantityStock
5 mg $58.30 In stock
10 mg $98.50 In stock
25 mg $200.70 In stock
100 mg $551.30 In stock
Bulk Quote

Quicklinks

Description

(E,Z)-4-Hydroxytamoxifen is a mixture of cis- and trans-isomers of 4-hydroxytamoxifen. 4-Hydroxytamoxifen is the active metabolite of tamoxifen, a selective estrogen receptor modulator (SERM) that acts as an agonist or antagonist in various tissues. 4-Hydroxytamoxifen exhibits anticancer chemotherapeutic activity, inducing autophagy and vacuole formation as well as KRAS degradation in various cancer cell lines. In cardiac myocytes, 4-hydroxytamoxifen decreases Ca2+ amplitude, slowing relaxation and decreasing contractility.

Product Info

Cas No.

68392-35-8
Purity

≥97%
Formula

C26H29NO2

Formula Wt.

387.51
IUPAC Name

4-[(Z)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol
Synonym

Afimoxifene
Appearance

White to off white powder

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

H9716 MSDS PDF
Info Sheet

H9716 Info Sheet PDF

References

Zhao Z, Wang B, Wu S, et al. Regulated control of virus replication by 4-hydroxytamoxifen-induced splicing. Front Microbiol. 2023 Mar 13:1112580. PMID: 36992923.

Asp ML, Martindale JJ, Metzger JM. Direct, differential effects of tamoxifen, 4-hydroxytamoxifen, and raloxifene on cardiac myocyte contractility and calcium handling. PLoS One. 2013 Oct 24;8(10):e78768. PMID: 24205315.

Kohli L, Kaza N, Coric T, et al. 4-Hydroxytamoxifen induces autophagic death through K-Ras degradation. Cancer Res. 2013 Jul 15;73(14):4395-405. PMID: 23722551.

Schwartz JA, Zhong L, Deighton-Collins S, et al. Mutations targeted to a predicted helix in the extreme carboxyl-terminal region of the human estrogen receptor-alpha alter its response to estradiol and 4-hydroxytamoxifen. J Biol Chem. 2002 Apr 12;277(15):13202-9. Erratum in: J Biol Chem 2002 Jul 5;277(27):24842. PMID: 11823467.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • T1004

    Paclitaxel Oxetane Ring-Opened 3-Acetyl 4-Benzoyl Impurity

    Synthesis impurity

    ≥92%
  • P0344

    Palbociclib Isethionate

    CDK4/6 inhibitor.

    ≥98%
  • A7657

    Atosiban Acetate

    Peptide, alters uterine contractility; V1/2 and...

    ≥95%
  • H9712

    (E)-4-Hydroxytamoxifen

    SERM.

    ≥97%
  • W317520

    WIN 55,212-2 Mesylate

    Non-selective cannabinoid receptor agonist.

    ≥98%
  • T0002

    T2 Toxin

    Trichothecene mycotoxin produced by Fusarium, a...

    ≥98%
  • R1877

    all-trans-Retinol, ≥98 %

    Diterpene vitamin A; RAR/RXR agonist.

    ≥98%
  • I0518

    I-BET-762

    BRD inhibitor.

    ≥98%
  • M0374

    Masitinib

    PDGFR and c-Kit inhibitor.

    ≥99%
  • F4883

    Flutriafol

    Triazole; demethylation inhibitor, NMDA agonist...

    ≥97%
  • G691343

    Griseofulvin

    Fungistatic

    ≥98%
  • M2409

    MGCD-0103

    HDAC inhibitor.

    ≥98%
  • D564090

    7-epi-Docetaxel

    Docetaxel impurity

    ≥95%
  • K0023

    K252c

    Staurosporine analog; PKC and PKA inhibitor.

    ≥98%
  • G0106

    Gabapentin

    GABA analog; GABA potentiator, adenosine A1 ago...

    ≥98%
  • E6782

    S-Equol

    Isoflavone, phytoestrogen found in soy; ER agon...

    ≥99%
  • E6783

    R-Equol

    Isoflavone, phytoestrogen found in soy

    ≥98%
  • I0480

    Ibudilast

    PDE3/5 inhibitor, LTD4 antagonist.

    ≥98%
  • C0374

    β-Casomorphin, human

    Peptide, casein fragment.

    ≥95%
  • V9202

    VX-702

    p38 MAPK inhibitor.

    ≥98%